The AI in Business Podcast

Enterprise CX teams have poured budget into AI, yet many still can't show measurable returns — frontline staff double-check the tools, and each new bot becomes another disconnected silo. ​ In this episode, John McMullan, Head of Product Marketing and Strategy at Observe.AI, joins ...  Show more

Enterprise CX teams have poured budget into AI, yet many still can't show measurable returns — frontline staff double-check the tools, and each new bot becomes another disconnected silo. ​ In this episode, John McMullan, Head of Product Marketing and Strategy at Observe.AI, joins ...  Show more

A single misstep in a new customer service channel can undo months of trust-building work. In this episode, Paul Cuglietta, Customer Services Director at Simplyhealth, explores how disciplined testing, governance, and stakeholder sign-off shape agentic AI rollouts inside a regula ...  Show more

An AI agent can function as designed yet produce results an organization cannot verify or safely use. In this episode, Melissa Ramey, Director, AI Transformation – Data Insights and User Experience at Salesforce, joins Emerj's Yolandi de Weerdt to examine who owns agent behavior ...  Show more

Drug discovery teams are running short of new ideas to test, and AI models that simulate how cells respond to drugs only pay off once leaders know when those predictions can be trusted with experiments, timelines, and budget. In this episode, Daniel Veres, Co-Founder and Chief Sc ...  Show more

In biopharma R&D, AI investment has overwhelmingly targeted generating more drug candidates, even though the industry has rarely lacked for compounds worth pursuing. In this episode, Mukhtar Ahmed, Director of Project and Portfolio Strategy at Greenstone Biosciences, explores why ...  Show more